SEC Form 4 · accession 0001127602-15-014649
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martine A Rothblatt
Officer — Chairman & Co-CEO · Director
Period of report
Apr 15, 2015
Accepted (ET)
Apr 16, 2015 · 9:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 15, 2015 | M | 2,211 | $63.22 | A | 2,451 | D | |
| Common StockF2 | Apr 15, 2015 | S | 300 | $184.6267 | D | 2,151 | D | |
| Common StockF3 | Apr 15, 2015 | S | 1,400 | $185.5204 | D | 751 | D | |
| Common StockF4 | Apr 15, 2015 | S | 511 | $186.76 | D | 240 | D | |
| Common StockF5 | Apr 16, 2015 | M | 4,115 | $34.56 | A | 4,355 | D | |
| Common StockF6 | Apr 16, 2015 | S | 4,115 | $186.3921 | D | 240 | D | |
| Common StockF5 | Apr 16, 2015 | M | 5,547 | $30.75 | A | 5,787 | D | |
| Common StockF7 | Apr 16, 2015 | S | 700 | $186.2914 | D | 5,087 | D | |
| Common StockF8 | Apr 16, 2015 | S | 1,100 | $186.99 | D | 3,987 | D | |
| Common StockF9 | Apr 16, 2015 | S | 2,219 | $188.1967 | D | 1,768 | D | |
| Common StockF10 | Apr 16, 2015 | S | 1,228 | $189.0691 | D | 540 | D | |
| Common StockF11 | Apr 16, 2015 | S | 300 | $189.90 | D | 240 | D | |
| Common Stock | holding | — | — | — | 166 | I | By Spouse | |
| Common Stock | holding | — | — | — | 579,065 | I | By Trusts |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options | $63.22 | Apr 15, 2015 | M | 2,211 | D | Dec 31, 2010 | Dec 31, 2020 | Common Stock | 2,211 | 428,953 | D |
| Stock OptionsF5 | $34.56 | Apr 16, 2015 | M | 4,115 | D | Dec 30, 2005 | Dec 30, 2015 | Common Stock | 4,115 | 127,580 | D |
| Stock OptionsF5 | $30.75 | Apr 16, 2015 | M | 5,547 | D | Dec 26, 2009 | Dec 31, 2017 | Common Stock | 5,547 | 493,648 | D |
Explanation of responses
- F1This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
- F10This transaction was executed in multiple trades at prices ranging from $188.70 to $189.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F11This transaction was executed in multiple trades at prices ranging from $189.87 to $189.93. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2This transaction was executed in multiple trades at prices ranging from $183.99 to $184.97. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3This transaction was executed in multiple trades at prices ranging from $185.08 to $186.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4This transaction was executed in multiple trades at prices ranging from $186.41 to $187.035. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5Exercise price and number of shares/awards has been adjusted to reflect the issuer's two-for-one stock split on September 22, 2009.
- F6This transaction was executed in multiple trades at prices ranging from $186.22 to $186.62. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7This transaction was executed in multiple trades at prices ranging from $185.59 to $186.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8This transaction was executed in multiple trades at prices ranging from $186.65 to $187.43. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9This transaction was executed in multiple trades at prices ranging from $187.70 to $188.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.